Treatment of Advanced Colorectal Cancer with High-dose Intensity Folinic Acid and 5-Fluorouracil Plus Supportive Care

By Petrioli R.   Lorenzi M.   Aquino A.   Marsili S.   Frediani B.   Palazzuoli V.   Marzocca G.   Botta G.   Tani F.   De Martino A.   Testi W.   Setacci C.   Salvestrini F.   De Sando D.   Bovenga S.   Mariani L.   Mancini S.   Tanzini G.   Armenio S.   Marinello E.   Francini G.  

European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. : 2105-2108

Elsevier

Access to resources Recommend Favorite

A Phase I Study of FAP (5-Fluorouracil, -Interferon and Cisplatin) Combined with Methotrexate for the Treatment of Advanced Urothelial Malignancies

By Shi-Ming T.   Robinson E.D.   Amato R.J.   Ellerhorst J.A.   Kilbourn R.G.   Logothetis C.J.  

Urologic Oncology: Seminars and Original Investigations, Vol. 1, Iss. 4, 1995-07 ,pp. : 156-160

Elsevier

Access to resources Recommend Favorite

Outpatient 5-Fluorouracil, Folinic Acid and Cisplatin in Patients with Advanced Esophageal Carcinoma

By Warner Ellen   Jensen Jorgen L.   Cripps Christine   Khoo Kong E.   Goel Rakesh   Kerr Ian A.   Bjarnason Georg A.   Fields Anthony L. A.   Hrincu Angela  

Acta Oncologica, Vol. 38, Iss. 2, 1999-03 ,pp. : 255-259

Informa Healthcare

Access to resources Recommend Favorite

High Dose 5-Fluorouracil (5-FU) and Folinic Acid in Advanced Colorectal Cancer Resistant to Standard Dose 5-FU Treatment: Results of a Phase II Study

By Jager E.   Klein O.   Wachter B.   Muller B.   Braun U.   Knuth A.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1717-1717

Elsevier

Access to resources Recommend Favorite

Treatment of advanced gastric cancer with etoposide, folinic acid, and fluorouracil in the clinical setting: Efficacy of therapy and value of serum tumor markers

By Schulze-Bergkamen Henning   Zuna Ivan   Teufel Andreas   Stremmel Wolfgang   Rudi Jochen  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 43-53

Humana Press, Inc

Access to resources Recommend Favorite